Sofie Arnetorp
Impact in
-
- Asthma and respiratory diseases
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Asthma and respiratory diseases 5
- Co-authors
- Cassandra Nan (2 shared papers)Claudia Cabrera (2 shared papers)Ralf J.P. van der Valk (2 shared papers)Jennifer Kathleen Quint (4 shared papers)Chloë I. Bloom (1 shared paper)Maarten J. H. I. Beekman (1 shared paper)Cátia Ferreira (1 shared paper)Sabada Dube (3 shared papers)
- Journals
- Advances in Therapy (2 papers)Respiratory Medicine (2 papers)Vaccines (2 papers)BJGP Open (1 paper)The Lancet Regional Health - Europe (1 paper)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Sofie Arnetorp
15 papers receiving 377 citations
Sofie Arnetorp's Hit Papers
Peers
Comparison fields: 5 of 48
- Physiology 177
- Infectious Diseases 77
- Pulmonary and Respiratory Medicine 84
- Modeling and Simulation 7
- Health 11
Countries citing papers authored by Sofie Arnetorp
This map shows the geographic impact of Sofie Arnetorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Arnetorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Arnetorp more than expected).
Fields of papers citing papers by Sofie Arnetorp
This network shows the impact of papers produced by Sofie Arnetorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Arnetorp. The network helps show where Sofie Arnetorp may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Arnetorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study Hit paper breakdown → | 2023 | 121 |
| 2 | 2020 | 92 | |
| 3 | 2022 | 67 | |
| 4 | 2019 | 48 | |
| 5 | 2020 | 20 | |
| 6 | 2022 | 13 | |
| 7 | 2013 | 9 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 0 |
About Sofie Arnetorp
Sofie Arnetorp is a scholar working on Infectious Diseases, Physiology, Clinical Psychology, Modeling and Simulation and Health, having authored 16 papers that have together received 389 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), COVID-19 and Mental Health (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), COVID-19 epidemiological studies (2 papers), Vaccine Coverage and Hesitancy (2 papers), Long-Term Effects of COVID-19 (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). The work is most often cited by research in Physiology (177 citations), Infectious Diseases (77 citations), Pulmonary and Respiratory Medicine (84 citations), Modeling and Simulation (7 citations) and Health (11 citations). Sofie Arnetorp has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Cassandra Nan, Claudia Cabrera, Ralf J.P. van der Valk, Jennifer Kathleen Quint, Chloë I. Bloom, Maarten J. H. I. Beekman, Cátia Ferreira, Sabada Dube, Sudhir Venkatesan and Yi Lu. Their work appears in journals such as Advances in Therapy, Respiratory Medicine, Vaccines, BJGP Open and The Lancet Regional Health - Europe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.